These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18344409)

  • 1. Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome.
    Boesze-Battaglia K; Damek-Poprawa M; Mitchell DC; Greeley L; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
    J Lipid Res; 2008 Jul; 49(7):1488-99. PubMed ID: 18344409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
    Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
    Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
    Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
    Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome.
    Kapphahn RJ; Richards MJ; Ferrington DA; Fliesler SJ
    Exp Eye Res; 2019 Jan; 178():247-254. PubMed ID: 30114413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species.
    Ford DA; Monda JK; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
    J Neurochem; 2008 May; 105(3):1032-47. PubMed ID: 18182048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ
    Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Xu L; Sheflin LG; Porter NA; Fliesler SJ
    Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
    Fliesler SJ; Xu L
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
    Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
    J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model.
    Gaoua W; Wolf C; Chevy F; Ilien F; Roux C
    J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
    Kolf-Clauw M; Chevy F; Ponsart C
    J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
    Keller RK; Arnold TP; Fliesler SJ
    J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome.
    Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C
    Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
    Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
    Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
    Fliesler SJ; Richards MJ; Miller C; Peachey NS
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome.
    Fliesler SJ; Vaughan DK; Jenewein EC; Richards MJ; Nagel BA; Peachey NS
    Pediatr Res; 2007 Mar; 61(3):273-8. PubMed ID: 17314682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
    Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
    Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
    Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
    J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
    Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
    J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
    Paila YD; Murty MR; Vairamani M; Chattopadhyay A
    Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.